ZYBT Stock News & Catalysts – Zhengye Biotechnology

FEATURED

Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement

Jilin, China, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research,

Summary

Aug 6, 2026, 8:00 AM ·Globe Newswire

RECENT

Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity

Jilin, China, July 21, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research,

Jul 21, 2026, 8:30 AM ·Globe Newswire

Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Jilin, China, June 04, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing,

Jun 4, 2026, 4:05 PM ·Globe Newswire

Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results

JILIN, China, April 28, 2026 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development,

Apr 28, 2026, 4:30 PM ·PRNewswire

Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure

Jilin, China, April 06, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development,

Apr 6, 2026, 9:25 AM ·Globe Newswire

Zhengye Biotechnology Holding Limited Issues 2026 Chairman's Letter to Shareholders

Jilin, China, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing,

Feb 10, 2026, 8:30 AM ·Globe Newswire

Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results

JILIN, China, July 3, 2025 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development,

Jul 3, 2025, 8:30 AM ·PRNewswire

Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F

Jilin, China, May 23, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing,

May 23, 2025, 4:05 PM ·Globe Newswire

Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option

Jilin, China, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research,

Jan 14, 2025, 12:00 PM ·Globe Newswire

Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering

Jilin, China, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research,

Jan 8, 2025, 12:00 PM ·Globe Newswire

Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering

Jilin, China, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development,

Jan 6, 2025, 5:50 PM ·Globe Newswire

Zhengye Biotechnology Holding Limited ZYBT · News